Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis

Purpose: Ranolazine is a novel anti-angina treatment approved in the United States for chronic stable angina. Ranolazine pharmacokinetics have not been studied previously in patients who receive maintenance hemodialysis. This study describes the pharmacokinetics of ranolazine and three major metabol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ren Fail
Autors principals: Scoville, Bridget A., Segal, Jonathan H., Salama, Noha N., Heung, Michael, Bleske, Barry E., Eyler, Rachel F., Mueller, Bruce A.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442103/
https://ncbi.nlm.nih.gov/pubmed/30909832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2019.1585371
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars